Evaluating Interventions for Alcohol Use Disorder
Not Applicable
Completed
- Conditions
- Alcoholism
- Interventions
- Behavioral: Motivational Enhancement TherapyOther: FC AssessmentOther: IB AssessmentBehavioral: Cognitive Behavioral Therapy
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 140
- Registration Number
- NCT02409888
- Locations
- 🇺🇸
Rutgers University School of Public Health, New Brunswick, New Jersey, United States
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Phase 2
Withdrawn
- Conditions
- Human Papillomavirus InfectionHealthy Subject
- Interventions
- Drug: carrageenan-containing gelOther: PlaceboOther: Laboratory Biomarker AnalysisOther: Questionnaire Administration
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Registration Number
- NCT02382419
- Locations
- 🇺🇸
Rutgers New Jersey Medical School, Newark, New Jersey, United States
Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor
- Interventions
- Drug: Oral ONC201Other: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 26
- Registration Number
- NCT02324621
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Not Applicable
Completed
- Conditions
- Recurrent Skin CancerSquamous Cell Carcinoma of the Skin
- Interventions
- Biological: cetuximabOther: laboratory biomarker analysis
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 15
- Registration Number
- NCT02324608
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
Phase 2
Active, not recruiting
- Conditions
- Stage IIA Breast CancerStage IIB Breast CancerEstrogen Receptor-negative Breast CancerHER2-negative Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerTriple-negative Breast CancerProgesterone Receptor-negative Breast Cancer
- Interventions
- Procedure: therapeutic conventional surgeryOther: laboratory biomarker analysisOther: quality-of-life assessment
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 62
- Registration Number
- NCT02315196
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity
Not Applicable
Withdrawn
- Conditions
- Stage III Squamous Cell Carcinoma of the Lip and Oral CavityStage IVB Verrucous Carcinoma of the Oral CavityStage IVB Squamous Cell Carcinoma of the Lip and Oral CavityStage III Verrucous Carcinoma of the Oral CavityTongue CancerStage IVA Squamous Cell Carcinoma of the Lip and Oral CavityStage IVA Verrucous Carcinoma of the Oral Cavity
- Interventions
- Radiation: hypofractionated radiation therapyRadiation: intensity-modulated radiation therapyProcedure: therapeutic conventional surgeryOther: laboratory biomarker analysis
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Registration Number
- NCT02295540
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸New Jersey Medical School, Newark, New Jersey, United States
E-cigarette vs. Nicotine Inhaler Comparisons
Not Applicable
Completed
- Conditions
- Smoking
- Interventions
- Other: Electronic CigaretteOther: Nicotrol Inhaler
- First Posted Date
- 2014-11-19
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 41
- Registration Number
- NCT02294617
Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
Not Applicable
Terminated
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 1
- Registration Number
- NCT02289989
- Locations
- 🇺🇸
Department of Dermatology. Rutgers-RWJMS, Somerset, New Jersey, United States
Oral ONC201 in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- Drug: Oral ONC201
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 58
- Registration Number
- NCT02250781
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease
Not Applicable
Terminated
- Conditions
- Graft Versus Host Disease
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 1
- Registration Number
- NCT02203578
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath